Loading provider…
Loading provider…
Hematology & Oncology Physician in Los Angeles, CA
NPI: 1053739805Primary Employer
USC Care Medical Group, Inc
keckmedicine.org
HQ Phone
Get MD Eric's Phone Numberphone_androidMobile
Get MD Eric's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2015 - 2027
NV State Medical License
2024 - 2025
NY State Medical License
2016 - 2020

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology

National Board of Physicians and Surgeons
Hematology

National Board of Physicians and Surgeons
Internal Medicine

National Board of Physicians and Surgeons
Medical Oncology
Stanford Health Care
Fellowship • Blood & Bone Marrow Transplant
2019 - 2020
SUNY Downstate Health Sciences University
downstate.edu
Fellowship • Hematology and Medical Oncology
2016 - 2019
Keck School of Medicine of USC
keck.usc.edu
Executive MBA
2023 - 2025
Woodhull Medical and Mental Health Center
Residency • Internal Medicine
2013 - 2016
St. George's University School of Medicine
Medical School
Until 2013
David Geffen School of Medicine at UCLA
medschool.ucla.edu
BS • Chemical Engineering
2001 - 2007
University of Pennsylvania
Post Baccalaureate • Special Science Program
2008 - 2009
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 36 | 111 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 32 | 133 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 30 | 151 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 26 | 191 |
| 5 | 99221Initial hospital inpatient care, typically 30 minutes per day | 13 | 14 |
Prolonged cardiac arrest complicating a massive ST-segment elevation myocardial infarction associated with marijuana consumption
Authors: Jose Orsini
Publication Date: 2016-09
Post-stem cell transplant maintenance in FLT3mut acute myeloid leukemia - A retrospective analysis: Outcomes are improved with midostaurin but not with gilteritinib.
Authors: Karrune Woan, Krithika Chennapan, George Yaghmour, Abdullah Ladha, Anastasia Martynova, Preet Chaudhary
Publication Date: 2024-01-11
Authors: Karrune Woan, George Yaghmour, Abdullah Ladha, Imran Siddiqi, Anastasia Martynova, Preet Chaudhary
Journal: EJHaem
Publication Date: 2024-04-08
Lead Sponsor: Kura Oncology, Inc.
Intervention / Treatment: DRUG: Cytarabine, DRUG: Fludarabine, DRUG: Ziftomenib, DRUG: Idarubicin, DRUG: Gilteritinib, BIOLOGICAL: Granulocyte colony-stimulating factor
Lead Sponsor: Syndax Pharmaceuticals
Intervention / Treatment: DRUG: Axatilimab
Lead Sponsor: Taiho Oncology, Inc.
Intervention / Treatment: DRUG: Venetoclax, DRUG: Decitabine and Cedazuridine (ASTX727)